Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Deferred Taxes (2016 - 2019)

Assembly Biosciences (ASMB) has 4 years of Deferred Taxes data on record, last reported at -$741000.0 in Q4 2019.

  • For Q4 2019, Deferred Taxes fell 165.06% year-over-year to -$741000.0; the TTM value through Sep 2020 reached -$741000.0, down 167.0%, while the annual FY2021 figure was -$2.5 million, N/A changed from the prior year.
  • Deferred Taxes reached -$741000.0 in Q4 2019 per ASMB's latest filing, down from -$15000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $1.1 million in Q4 2018 and bottomed at -$9.0 million in Q4 2017.
  • Average Deferred Taxes over 4 years is -$932348.7, with a median of -$24500.0 recorded in 2018.
  • Peak YoY movement for Deferred Taxes: crashed 1355.43% in 2017, then surged 112.66% in 2018.
  • A 4-year view of Deferred Taxes shows it stood at -$618000.0 in 2016, then plummeted by 1355.43% to -$9.0 million in 2017, then soared by 112.66% to $1.1 million in 2018, then plummeted by 165.06% to -$741000.0 in 2019.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were -$741000.0 in Q4 2019, -$15000.0 in Q3 2019, and -$11000.0 in Q2 2019.